AbCellera Biologics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; AbCellera Biologics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is €-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 12.36M	$ 6.60M	$ 10.06K	$ 15.79K	$ 21.55M
Gross Profit	$ 12.36M	$ 6.60M	$ 10.06K	$ 15.79K	$ 19.99M
EBIT	$ -48.60M	$ -39.28M	$ -38.00K	$ -48.15K	$ -20.02M
EBITDA	$ -39.49M	$ -31.87M	$ -30.75K	$ -41.03K	$ -4.66M
Net Income Common Stockholders	$ -47.15M	$ -28.61M	$ -30.53K	$ -40.11K	$ -29.89M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 760.59M	$ 785.84M	$ 795.69K	$ 796.50K	$ 886.49M
Total Assets	$ 1.49B	$ 1.51B	$ 1.54M	$ 1.50M	$ 1.54B
Total Debt	$ 84.49M	$ 80.76M	$ 84.03K	$ 83.13K	$ 82.26M
Net Debt	$ -676.09M	$ -705.08M	$ -711.66K	$ -713.36K	$ -804.23M
Total Liabilities	$ 335.78M	$ 329.42M	$ 342.34K	$ 289.42K	$ 307.63M
Stockholders Equity	$ 1.15B	$ 1.18B	$ 1.19M	$ 1.21M	$ 1.23B
Cash Flow	-
Free Cash Flow	$ -34.04M	$ -21.00M	$ -7.30K	$ -59.05K	$ 18.58M
Operating Cash Flow	$ -19.61M	$ -106.00K	$ 19.90K	$ -44.06K	$ 30.91M
Investing Cash Flow	$ -24.32M	$ -12.79M	$ -34.39K	$ -149.61K	$ -17.06M
Financing Cash Flow	$ 3.77M	$ 6.63M	$ 419.00	$ -458.00	$ 349.00K

Currency in USD

AbCellera Biologics Earnings and Revenue History

Income Statement >

AbCellera Biologics Debt to Assets

Balance Sheet >

AbCellera Biologics Cash Flow

Cash Flow >

AbCellera Biologics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing